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Original Article
Deep sternal infections after in situ bilateral internal thoracic 
artery grafting for left ventricular myocardial revascularization: 
predictors and influence on 20-year outcomes
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Background: The incidence and potential factors influencing deep sternal wound infection (DSWI) in a 
cohort of patients undergoing coronary artery bypass grafting (CABG) using skeletonized bilateral internal 
thoracic artery (BITA) was explored. Furthermore, we studied influence of DSWI on long-term survival, 
major adverse cardiac events (MACEs) and repeat coronary revascularization (RCR).
Methods: The study cohort consisted of 1,325 consecutive patients who were divided in two groups: 
patients experiencing DSWI (n=33, group 1) and those who did not have sternal infection (n=1,292, group 2).  
A logistic regression model was employed to find predictors of DSWI whereas Cox regression and a 
competing risk models were carried out to test predictors of late death, MACE and RCR, respectively. 
Follow up was 100% complete and ranged from 1 to 245 months. Median follow-up was 103 months (IQR, 
61 to 189 months). Cumulative follow-up was 16,430 patient years.
Results: The incidence of DSWI was 2.4%. Multivariable logistic regression analysis found any single 
independent predictor of DSWI. However, the association of peripheral vascular disease (PVD) and diabetes 
increased the risk by 1.4 and 1.6 times. When DM was associated with obesity the risk increased by 2.1 and  
2.6 times compared to the single factors, respectively. Obese female patients were at a 1.6-fold higher risk 
when compared to the association of DM with obesity. DSWI was not an independent predictor of long-
term survival (HR, 2.31; 95% CI: 0.59–9.12), RCR (SHR, 2.89; 95% CI: 0.65–10.12), or MACE (SHR, 1.98; 
95% CI: 0.44–8.56).
Conclusions: With an accurate patient selection (i.e., exclusion of obese diabetic females) and strict 
DM control BITA represents a first choice for most of CABG patients, even at high risk for DSWI. The 
occurrence of DSWI does not influence long-term survival and late outcomes. Our findings should be 
confirmed by further larger research.
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Introduction
The left internal thoracic artery (LITA) is considered as the 
gold-standard conduit for the revascularization of the left 
anterior descending artery (LAD) with higher long-term 
patency rates (1), enhanced survival and lower incidence of 
cardiac events (2). Many studies have indicated that bilateral 
ITA grafting (BITA) further improves survival and reduces 
the need for repeat revascularization (3-9). Nevertheless, 
many surgeons avoid bilateral ITA grafting because of 
the potential for an increased risk of deep sternal wound 
infection (DSWI). Skeletonization of the ITA has emerged 
as a suitable solution to sternal wound complications 
following BITA, allowing the preservation of the collateral 
blood supply to the sternum and thus reducing the 
incidence of parietal damage (10-16).
Risk factors for DSWI have been amply explored in the 
past to identify patients carrying the greatest intrinsic risk 
of DSWI (17-20). The association of DSWI with bilateral 
ITA grafting has been controversial. A number of studies 
have demonstrated a significant risk (21-23) whilst others 
have shown an increased although nonsignificant risk (24) 
and one study showed no risk at all (25). In addition, the 
true effect of BITA skeletonization on sternal perfusion and 
clinical outcomes remains under debate (26). Furthermore, 
long-term survival and the mortality profile of patients with 
DSWI after hospital admission have been poorly evaluated 
(27-29) and little is known regarding the influence of DSWI 
on other long-term outcomes.
Therefore, we have studied the incidence and potential 
factors influencing DSWI in a cohort of patients undergoing 
skeletonized BITA CABG using the same technique over 
time to test the hypothesis that this technique reduces the 
incidence of DSWI also in high risk patients. Finally, we 
explored the influence of DSWI on long-term survival, 
major adverse cardiac events (MACE) and repeat coronary 
revascularization (RCR).
Methods
Ethical Committee approval was waived due to the 
retrospective analysis of the study according to National 
Laws regulating observational retrospective studies (Italian 
law nr.11960, released on 13/07/2004). However, written 
informed consent was obtained from all the patients 
subjected to the surgical procedure and the treatment of 
data for scientific purposes which complied with Europe’s 
General Data Protection Regulation.
Between January 1997 and May 2017,  patients 
undergoing coronary artery bypass grafting (CABG) with 
in situ skeletonized BITA to the left coronary circulation 
were enrolled for this study (Figure 1). Inclusion criteria 
were the presence of at least two angiographically branches 
of the left coronary circulation graftable with bilateral 
skeletonized ITAs. Myocardial viability under target stenotic 
coronary artery was detected with echocardiography, stress 
testing or nuclear magnetic resonance, if necessary. Patients 
receiving RITA on LAD, RITA on a right coronary branch, 
those with free or Y grafts, or those receiving a venous graft 
were excluded.
Clinical and instrumental data were prospectively 
recorded in a dedicated database. Follow-up data were 
collected by telephone interviews with the patients 
themselves or family members as well as from subsequent 
hospital records, the patient’s physician or outpatient 
clinics.
Definitions and outcomes
Primary outcome was DSWI, defined as an infection 
involving the muscle, bone and/or mediastinum that 
occurred within 30 days of surgery, required operative 
intervention (incision and drainage or re-exploration), 
had positive cultures if obtained and the patient was not 
previously on antibiotics at the time of sampling, and 
LIMA to LAD
RIMA to OMA
Figure 1  Picture summarizing the main geometric graft 
configuration for total myocardial arterial revascularization 
(TAMR). 
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received antibiotic treatment beyond routine perioperative 
prophylaxis (30).
Secondary outcomes were long-term survival, MACE and 
RCR. MACE included cardiac death, nonfatal myocardial 
infarction (MI) or angina, target vessel revascularization, 
heart failure and stroke. RCR included repeat CABG or 
percutaneous coronary intervention (PCI).
Postoperative MI was defined as an increase in biomarker 
values above five times the 99th percentile of the normal 
reference range during the initial 72 hours following 
CABG, associated with the appearance of new pathological 
Q-waves or new left bundle branch block (LBBB), or 
angiographically documented new graft or native coronary 
artery occlusion, or imaging evidence of new loss of viable 
myocardium (31).
Surgical technique
The target for skeletonized in situ LITA was the LAD and, 
eventually, its branches (with sequential or composite graft). 
The target of the remaining left coronary circulation for 
skeletonized in situ RITA (Figure 1) grafting was selected as 
follows: in patients with two graftable branches, the branch 
with the larger perfusion area was selected as a primary 
target; if both branches had identical perfusion areas, the 
distal branch was selected as target for RITA grafting 
and the other vessel was re-vascularized with composite, 
sequential ITA grafts or other available conduits if indicated. 
In patients with heavily calcified aorta OPCAB-BITA 
represented first choice to reduce the risk of embolism of 
calcified plaques. Care was taken throughout the surgery 
to keep the pleurae closed, to spare the communicating 
bifurcation of the ITAs to the chest wall and to preserve the 
pericardiacophrenic artery branches. The ITAs free flow 
was evaluated intraoperatively and, in all cases, was >50 mL/
min and therefore all ITAs were employed. In case a radial 
graft was planned, the artery was harvested from the non-
dominant arm after a preoperative assessment of the palmar 
arch with the Allen test. Digital plethysmography was 
carried out in a number of doubtful cases.
Statistical analysis
To address missing values for variable (Table S1) we used 
fully conditional specification multiple imputation method 
(1,000 replications) (32).
The normality of distribution was assessed using 
the Kolmogorov-Smirnov test. Continuous data were 
summarized as mean and standard deviation or median and 
twenty-fifth to seventy-fifth percentiles in case of skewed 
distributions. Categorical variables were reported as counts 
and percentages.
Comparisons were carried out using chi-square, Fisher’s 
and Mann-Whitney tests where appropriate. Forty-
two parameters (supplementary) were considered in the 
initial model for their predictive value. To enhance the 
accuracy of the model, the number of variables was reduced 
using variable clustering (33). All variables with P<0.2 
at univariate analysis were introduced into multivariable 
logistic regression with the forward stepwise method to 
identify predictors of DSWI. The model was adjusted by 
preoperative, intraoperative, and postoperative factors. 
We also tested for interaction terms between potential 
factors for sternal complications (obesity, female sex, 
diabetes mellitus (DM), chronic obstructive pulmonary 
disease (COPD), age ≥80 years, peripheral vascular disease 
(PVD) (34), and a sub analysis to calculate ORs of 
combining factors.
The Kaplan-Meier method and log-rank test were 
used for survival analysis. A Cox regression model was 
used to estimate predictors of death. The proportional 
hazard assumption was confirmed by use of Schoenfeld 
residuals.  Cumulative incidence curves were used 
for MACE and RCR and testing differences by the 
Gray test.
Finally, a competing risk analysis was used to avoid 
overestimation of the incidence of repeated revascularization 
and MACE.
R, release 3.2.3 (R Foundation for Statistical Computing, 
Wien, Austria) software and “survival”, “cmprsk” and 
“forestplot” packages were utilized. Significance for 
hypothesis testing was set at the 0.05 two-tailed level.
Results
Patients
The study population consisted of 1,325 patients (Table 1). 
Thirty-three patients (2.5%) presented with sternal 
wound infection (group 1) whereas 1,292 did not 
(group 2). Amongst those experiencing DSWI, 12 (0.9%) 
required surgical treatment or surgical re-exploration while 
the others were treated with incision and drainage. The 
time to DSWI diagnosis ranged between 3 and 22 days, 
5211
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2018;10(9):5208-5221jtd.amegroups.com
Journal of Thoracic Disease, Vol 10, No 9 September 2018
with a median of 11 days. After diagnosis was established, 
if surgical revision was necessary, debridement of necrotic 
tissue and topical treatment with antiseptic solution and 
VAC were carried out and secondary closure of the open 
chest wound was performed. Patients with DSWI were 
older (P=0.001), in a larger percentage female (P<0.001), 
diabetic (P<0.001), experienced PVD (P=0.01) or COPD 
(P=0.002). No other differences were detected amongst 
preoperative characteristics in the two Groups. Surgical data 
are given in Table 2. No differences were found between 
the two groups regarding surgical technique, number of 
anastomoses and graft geometry (all >0.5).
Early outcomes
Overall 30-day mortality was 1.4% (n=19). Causes of 
Table 1 Patient characteristics (n=1,325)
Characteristics Group 1: DSWI (n=33) Group 2: no-DSWI (n=1,292) P
Females 15 (45.5%) 269 (20.8%) <0.001
Mean age (years) 69.5±12.9 62.8±11.6 0.001
Diabetes 15 (45.5%) 315 (24.4%) <0.001
Hypertension 25 (75.8%) 921 (71.3%) 0.69
Smoking 13 (39.4%) 401 (31.0%) 0.25
Dyslipidemia 15 (45.5%) 549 (42.5%) 0.72
CKD 4 (12.1%) 119 (9.2%) 0.54
Previous CVD 2 (6.1%) 40 (3.1%) 0.30
PVD 7 (21.2%) 104 (8.1%) 0.01
COPD 8 (24.2%) 119 (9.2%) 0.002
NYHA 1.8±0.9 1.6±0.8 0.16
CCS 3.4±1.4 3.0±1.3 0.08
Stable angina 20 (60.6%) 739 (57.2%) 0.72
Unstable angina 13 (39.4%) 553 (42.8%) 0.72
Prior myocardial infarction 15 (45.5%) 697 (54.0%) 0.29
Prior coronary angioplasty 9 (27.3%) 419 (32.4%) 0.45
Heavily calcified aorta 4 (12.1%) 119 (9.2%) 0.54
Coronary angiography data
Three-vessel disease 21 (63.4%) 904 (70.0%) 0.44
Two-vessels disease 7 (21.2%) 322 (24.9%) 0.68
Left main coronary artery stenosis 12 (36.4%) 429 (33.2%) 0.70
LVEF 51.6±9.3
LVEF ≤35% 9 (27.3%) 292 (22.6%) 0.39
EUROSCORE II 3.1±0.9 2.9±0.8 0.05
STS 3.8±2.5 3.4±2.3 0.33
Data are shown as mean ± SD or numbers (percentage). CKD, chronic renal disease; CVD, cerebrovascular disease; PVD, peripheral 
vascular disease; COPD, chronic obstructive pulmonary disease; NYHA, New Heart Association Functional Class; CCS, Canadian 
Cardiovascular Society Angina Class; LVEF, left ventricular ejection fraction; STS, Society of Thoracic Surgeons.
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mortality were: acute MI (n=5), aortic dissection (n=2), 
low cardiac output (n=2), multi-organ failure (MOF, n=4), 
sepsis (n=2), low-limb ischemia (n=2) and mesenteric 
ischemia (n=2). Early mortality was higher in group 1 
(P<0.001).
Furthermore, amongst DSWI patients, mortality was 
significantly higher in diabetics [330/1,325 (24.9%) vs. 
15/33 (45.4%), P=0.003]. Other early outcomes are shown 
in Table 3. Patients with DSWI had longer ICU stay and 
ventilation time, needed more inotropic support and 
experienced more revision for bleeding, renal dysfunction, 
MOF or sepsis.
Predictors of DSWI
At multivariable logistic regression analysis (Table 4) found 
any single independent predictor of DSWI. However, we 
found significant interaction terms between PVD and DM 
(P=0.01), COPD and PVD (P<0.001), PVD and obesity 
(P=0.002), DM and obesity (P<0.001) and DM and COPD 
(P=0.008), DM and female sex (P=0.002) and female sex 
and obesity (P=0.001) A sub-analysis (Figure 2) showed that 
the association of PVD and DM increased the risk by 1.4 
and 1.6 times compared to the single variables, respectively. 
Furthermore, when PVD occurred with COPD the risk 
was >2 times higher than PVD alone and 2.7 times higher 
than COPD. Moreover, the association with obesity 
increased the risk of DSWI by PVD by 1.9 times and by 
obesity by 2.7 times. When DM was associated with obesity 
the risk increased by 2.1 and 2.6 times compared to the 
single factors, respectively. Additionally, the association 
of DM and COPD increased the risk by 1.9 and 2.3 times 
compared to the single variables, respectively. Finally, when 
we tested the association between more than 2 factors, 
obese female patients were at a 1.6-fold higher risk when 
compared to the association of DM with obesity.
Long-term results
Follow up was 100% complete and ranged from 1 to 
245 months. Median follow-up was 103 months (IQR, 61 
to 189 months). Cumulative follow-up was 16,430 patient 
years.
Actuar ia l  surviva l  at  5 ,  10,  and 15 years  were 
Table 2 Operative data (n=1,325)
Variables Group 1: DSWI (n=33) Group 2: no-DSWI (n=1,292) P
Urgent/emergent 12 (36.4%) 367 (28.4%) 0.24
Cardiopulmonary bypass time (minutes) 81.2±20.7 84.3±21.9 0.42
Aortic cross-clamping time (minutes) 63.4±15.9 65.1±16.6 0.56
OPCAB 13 (39.4%) 350 (27.1%) 0.54
Number of distal anastomoses per patients 3.2±0.7 3.4±0.8 0.16
Coronary artery endarterectomy 4 (12.1%) 100 (7.7%) 0.54
Sequential anastomoses 10 (30.3%) 355 (27.5%) 0.69
Sequential anastomosis with the in-situ RITA 1 (3.0%) 18 (1.4%) 0.47
Grafted to the IA 7 (21.2%) 231 (17.9%) 0.65
Grafted to the OM 18 (54.5%) 804 (62.2%) 0.47
Grafted to the PL 5 (15.2%) 260 (20.1%) 0.39
Retrocaval RITA routing 9 (27.3%) 443 (34.3%) 0.45
Radial artery employed 5 (15.2%) 233 (18.0%) 0.65
Arterial grafts/patients 2.7±0.7 2.5±0.6 0.06
BITA arterial grafts/patients 2.4±0.3 2.3±0.4 0.15
Data are shown as mean ± SD or numbers (percentage). OPCAB, off-pump coronary artery bypass; LITA, left internal thoracic artery; DA, 
diagonal branch of left descending artery; LAD, left descending artery; RITA, right internal thoracic artery; IA, intermediate artery; OM, 
obtuse marginal artery; PL, postero-lateral branch of the circumflex artery; RCA, right coronary artery.
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95.3% (94.1–96.6%) vs. 95.8% (88.2–100.0%), 90.1% 
(88.2–92.0%) vs. 86.7% (73.7–90.0%), 83.6% (80.9–86.4%) 
vs. 70.9% (53.5–93.9%) (all P>0.05) in group 1 and 2, 
respectively (Figure 3A). In addition, there was no difference 
in survival between the two groups in older patients, 
diabetic, obese or with PVD or COPD (Figure 3B,C,D,E,F).
Cumulative incidence of MACE at 5, 10, and 15 years 
(Figure 4A), were 2.13% (1.3–2.96%) vs. 8.7% (0.3–
10.53%), 7.4% (5.6–9.1%) vs. 13.0% (2.1–17.7%), 14.5% 
(11.9–17.1%) vs. 20.5% (3.7–34.9%) in group 1 and 2, 
respectively. There was no differences between the two 
groups (all P>0.05) also in older, diabetic, obese patients or 
patients suffering from PVD or COPD (Figure 4B,C,D,E,F).
Table 3 Early outcomes (n=1,325)
Variables Group 1: DSWI (n=33) Group 2: no-DSWI (n=1,292) P
30-day mortality 9 (27.3%) 10 (0.8%) <0.001
Intensive care unit stay (hours) 26.8±18.6 18.1±16.2 0.002
Mechanical ventilation (hours) 7.5±3.5 5.8±2.9 0.001
Prolonged ventilation (>24 hours) 19 (57.6%) 34 (2.6%) <0.001
Postoperative MCA 2 (6.1%) 22 (1.7%) 0.06
Surgical revision for bleeding 4 (12.1%) 32 (2.5%) <0.001
Postoperative MI 2 (6.1%) 21 (1.6%) 0.06
Inotropic use (dopamine >6 γ/kg/min) 6 (18.2%) 71 (5.5%) 0.003
Atrial fibrillation 3 (9.1%) 152 (11.8%) 0.59
Other arrhythmias 2 (6.1%) 47 (3.6%) 0.45
Renal dysfunction 6 (18.2%) 59 (4.6%) 0.003
Postoperative ultrafiltration/hemodialysis 1 (3.0%) 18 (1.4%) 0.47
Unilateral pleural effusion (chest X-ray) 2 (6.1%) 43 (3.3%) 0.38
Bilateral pleural effusion (chest X-ray) 1 (3.0%) 27 (2.1%) 0.71
Atelectasis during ICU 4 (12.1%) 99 (7.7%) 0.54
Pneumothorax 1 (3.0%) 48 (3.7%) 0.85
Diaphragm impairment 2 (6.1%) 38 (2.9%) 0.30
Bronchopneumonia 1 (3.0%) 28 (2.2%) 0.71
Gastro-intestinal complications 1 (3.0%) 23 (1.8%) 0.60
Transient neurological complications 2 (6.1%) 30 (2.3%) 0.17
Stroke 0 (0.0%) 5 (0.4%) 0.75
Multi organ failure 1 (3.0%) 6 (0.5%) 0.07
Sepsis 9 (27.3%) 2 (0.2%) < 0.001
Data are shown as mean ± SD or numbers (percentage). MCA, mechanical cardio-circulatory assistance; MI, myocardial infarction; ICU, 
intensive care unit.
Table 4 Predictors of DSWI
Variable OR 95% CI P
DM 7.42 0.57–42.8 0.17
COPD 6.25 0.67–32.47 0.14
Age ≥70 y 2.84 0.38–17.93 0.09
CKD 6.65 0.13–37.94 0.16
PVD 8.34 0.16–35.63 0.15
Obesity 6.26 0.87–71.54 0.19
Female sex 6.01 0.95–19.4 0.09
OR, odds ratio; DM, diabetes mell itus; COPD, chronic 
obstructive pulmonary disease; CKD, chronic renal disease; 
PVD, peripheral vascular disease.
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Figure 3 Actuarial survival. (A) Overall survival; (B) survival in patients older than 80 years; (C) survival in diabetic patients; (D) survival in 
obese patients; (E) survival in patients with peripheral vascular disease (PVD); (F) survival in patients with chronic obstructive pulmonary 
disease (COPD).
Figure 2 Predictors of deep sternal wound infection (DSWI). HR, hazard ratio; CI, confidence interval; PVD, peripheral vascular disease; 
COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus.
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Finally, cumulative incidence of RCR at 5, 10, and 
1 5  y e a r s  w e r e  4 . 9 6 %  ( 2 . 9 9 – 7 . 9 3 % )  v s .  1 0 . 5 % 
(1 .03–22.03%),  9 .32% (7 .44–11.21%) vs .  15 .2% 
(1.42–30.82%), 16.3% (13.6–18.9%) vs. 20.0% (4.3–37.9%) 
in group 1 and 2, respectively. It was comparable (P>0.05) 
between the two groups in the whole population (Figure 5A) 
and also by subgroups (Figure 5B,C,D,E,F).
Predictors of late outcomes
At Cox regression, LVEF <35%, COPD, PVD, chronic 
kidney disease (CKD) and age >80 (all P<0.001) were 
predictors of death at follow-up. Furthermore, at competing 
risk analysis, PVD and OPCAB (both, P<0.001) predicted 
RCR. Finally, age >80 years, PVD, LVEF <35%, OPCAB 
and COPD (all P<0.001) were independent predictors of 
MACE. In contrast, DSWI was not a significant predictor 
of death, RCR or MACE (Figure 6).
Discussion
Bilateral internal thoracic artery (BITA) has been proven 
to provide better event-free survival than single ITA 
(3-9). Nevertheless, concern about DSWI is one of the 
main reasons limiting the widespread use of BITA (35). 
Skeletonized harvesting has been proposed to minimize the 
risk of DSWI by preserving sternal perfusion especially in 
the context of BITA.
Since 1997, we have extensively employed the in-situ 
skeletonized BITA for left coronary circulation grafting 
(10,12,36,37) therefore, in this report we explored the 
occurrence of DSWI in our population and tried to identify 
Figure 4 Cumulative incidence of major adverse cardiac events (MACE). (A) Overall cumulative incidence; (B) cumulative incidence in 
patients older than 80 years; (C) cumulative incidence in diabetic patients; (D) cumulative incidence in obese patients; (E) cumulative 
incidence in patients with peripheral vascular disease (PVD); (F) cumulative Incidence in patients with chronic obstructive pulmonary 
disease (COPD).
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factors that may predict sternal infection.
In our experience, DSWI occurred in 2.5% of patients 
and this is in line with data between 0.5% and 6.8 shown 
in the literature (38) and comparable to 1.9% incidence 
recently reported by the recent ART trial for the BITA 
patients group (39) although the skeletonized technique was 
employed in the ART trial in approximatively half of the 
patients with BITA and 46% with SITA.
The role of diabetes as a major risk factor for DSWI 
has been extensively studied and the prevalence of diabetes 
has been found to be three times higher among patients 
with DSWI than those without DSWI (2,39,40) although 
diabetic patients may actually have the most to gain from 
BITA grafting (41). In this study, the incidence of DSWI 
in diabetic patients was 4.5% (15/330) and DM did not 
predict DSWI, although, in case of DSWI in diabetics, the 
mortality raised significantly. This is in accordance with 
other studies (5,7,15,16,42,43). However, the skeletonized 
harvesting technique could be responsible for these results 
since it that preserves collateral blood flow to the sternum, 
crucial in these patients in the absence of the ITA (39).
Though, we believe that the aggressive treatment 
received by our DM patients referred to CABG surgery 
is mandatory for positive outcomes. This is in line with 
Lazar et al. (44) who showed that preoperative hemoglobin 
A1c (HbA1c) levels were not predictive of early adverse 
outcomes following CABG if glycemic control was 
achieved. Indeed some authors suggest that preoperative 
HbA1c measurement should be taken in all patients, since 
it should reflect the adequacy of glycemic control when 
its level is less than 7% (45). This has been confirmed 
by Halkos et al. (46) who found a significant association 
Figure 5 Cumulative incidence of repeat coronary revascularization (RCR). (A) Overall cumulative incidence; (B) cumulative incidence 
in patients older than 80 years; (C) cumulative incidence in diabetic patients; (D) cumulative incidence in obese patients; (E) cumulative 
incidence in patients with peripheral vascular disease (PVD); (F) cumulative incidence in patients with chronic obstructive pulmonary disease 
(COPD).
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between HbA1c >7% and DSWI.
The current recommendation from the Society of 
Thoracic Surgeons guidelines is that oral hypoglycemics 
should be withheld for at least 24 h prior to surgery (45). 
In our practice, patients with a blood glucose concentration 
greater than 180 mg/dL (10.0 mmol/L) who are awaiting 
elective CABG receive a continuous insulin infusion to 
maintain their glucose concentration below 150 mg/dL 
(8.3 mmol/L). In these patients, we hourly measure 
intraoperative blood glucose concentrations, taking care 
to avoid perioperative hypoglycemia especially in patients 
with abnormal kidney function who should be promptly 
identified preoperatively (45). However, when DM is 
associated to obesity, PVD and COPD, the risk of DSWI 
raises by 2.1, 1.6 and 1.9 times, respectively. COPD is one 
of the most important risk factors for sternal dehiscence, 
and its prevalence is increasingly frequent in patients 
undergoing cardiac surgery (47). Discontinuation of 
smoking, clearance of secretions and prevention and relief 
of atelectasis, respiratory physiotherapy, including incentive 
spirometry, deep breathing exercises, expectoration, and 
bronchodilator therapy for 1 or 2 weeks before surgery and 
in the postoperative period are mandatory. Adopting these 
measures in this subset of patients led to the utilization 
of skeletonized- BITA CABG being safe in patients with 
COPD. In addition, we found obese diabetic to have a 
2.1-fold greater risk of DSWI but this risk increased, in 
the case of obese diabetic females—1.6-fold compared to 
the association of DM with obesity. This confirms findings 
previously reported by reported by Matsa et al. (48) and 
colleagues and stated by Lev-Ran and colleagues (49). 
Although our data must be read with caution due to the 
higher percentage of females in the DSWI patients and 
the unbalance between the two groups, our results might 
suggest that obese diabetic women should not undergo 
BITA grafting. This must be confirmed by larger studies.
Moreover, to the best of our knowledge, few reports in 
the literature have discussed long-term results following 
DSWI (27). In this report, we explore the influence of 
DSWI on late outcomes over 20 years. A strength of our 
study is the long follow up that, as far as we know, is one of 
the longest reported in the literature.
In our experience, DSWI did not influence 15-year 
survival and this was confirmed also in high-risk subgroups. 
Figure 6 Results of Cox regression analysis for death (top) and of competing risk analysis for repeat coronary revascularization (RCR) (middle) 
and major adverse cardiac events (MACEs) (bottom). Results of Cox regression are given as hazard ratio and 95% confidence interval 
whereas results of competing risk regression are given as sub-hazard ratio and 95% CI.
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In addition, DSWI did not predict survival whereas 
LVEF <35%, COPD, PVD, CKD, no-total-arterial 
revascularization and age >80 years were confirmed to be 
independent predictors of death (3,13,14). Our findings are 
in accordance with Colombier et al. (29) who showed that 
post-sternotomy deep wound infection does not influence 
long-term survival in a patient-matched population. 
Furthermore, our data is consistent with results reported 
by Cayci et al. (28), showing any influence of DSWI on 
long-term survival. In other words, if patients survive the 
critical postoperative phase, their life expectancy does not 
differ from that of patients without DSWI. In contrast, 
Toumpoulis et al. (50) found that DSWI following CABG 
was associated with increased long-term mortality during 
a 10-year follow-up study. These investigators, however, 
included postoperative variables which are complications 
and hence may not be true independent predictors of 
DSWI. Similarly to Ridderstolpe et al. (51) and Lu 
et al. (52), we performed adjustment for all preoperative, 
intraoperative, and postoperative factors. Nonetheless, 
looking at our findings, the reader must keep in mind that, 
since we included in the analysis both deep and superficial 
sternal infections, this might have lowered the reported 
HR since superficial infections are expected to have shown 
lower long-term mortality rates than deep infections.
Finally, even less information is available regarding the 
influence of DSWI on MACE and repeat revascularization 
that actually represents a novel finding of our study. Deep 
sternal infection was not a predictive factor neither for 
MACE or RCR. In contrast, age >80 years, PVD, LVEF 
<35%, presence of OPCAB and COPD (all P<0.001), 
were independent predictors of MACE whereas PVD and 
OPCAB (both, P<0.001) predicted RCR. We can postulate 
that to the higher over time patency rate of arterial graft 
compared to saphenous vein conduits, BITA technique 
is one of the main reasons of such positive outcomes and 
we cannot exclude that the use of skeletonized mammary 
artery also significantly contributed to reduction of these 
complications. Further research will clarify this matter.
Limitations
Our research has some limitations that need to be 
recognized. Firstly, the retrospective nature of the study 
does not enable us to draw final conclusions. Secondly, the 
number of DSWIs, as in most previous studies (50,53-55), 
was small. Thirdly, this study refers to a single-center 
database, and it is likely that selection of homogeneous 
population that represents the main strength of our study 
may also be a drawback since it may have introduced a 
selection bias. Fourthly, we did not make comparison 
between BITA vs. non-BITA, LITA + radial vs. LITA + 
SVGs etc. since this was beyond the aims of our paper. 
This will be, however, object of an oncoming paper. Fifthly, 
the target coronary vessels were determined mainly by 
the perfusion area of the recipient artery and not selected 
randomly and this may have introduced a bias. Finally, 
postoperative angiography was not routinely obtained 
therefore the patency of the grafts was unknown.
Conclusions
Skeletonized BITA, with an accurate patient selection (i.e., 
exclusion of obese diabetic females) and strict DM control 
should be considered the first choice for the majority of 
patients undergoing CABG due to its long-term patency 
and not adding a significant risk of DSWI. In addition, 
DSWI resulted not to be a continuing detrimental risk 
factor for long-term outcomes following CABG, showing 
that its negative effects did not extend beyond a 30-day time 
period. Larger randomized studies on this controversial 
matter are warranted.
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Supplementary
Variables
Baseline
Sex, age, age ≥70 years, diabetes, hypertension, smoking, 
dyslipidemia, chronic renal disease (CKD), cerebrovascular 
disease (CVD), peripheral vascular disease (PVD), chronic 
obstructive pulmonary disease (COPD), New Heart 
Association Functional Class (NYHA) ≥ III, Canadian 
Cardiovascular Society Angina Class (CCS) ≥ III, unstable 
angina, prior myocardial infarction (MI), ≥ three vessel-
disease, main coronary artery disease, left ventricular 
ejection fraction (LVEF) ≤35%, EuroScore II ≥6%, Society 
of Thoracic Surgeons (STS) ≥10%.
Intraoperative
Emergency, REDO, CPB time, CCT, OPCAB, number 
of anastomoses, coronary endarterectomy, sequential 
anastomosis, targeted obtuse marginal artery (OM) branch, 
total arterial myocardial revascularization (TAMR), 
composite graft.
Postoperative
ICU stay, mechanical ventilation >24 h, MI, AF, bleeding, 
renal dysfunction, CVVH, dialysis, stroke, MOF, surgical 
wound revision.
Table S1 Missing data
Variables Percentage (%)
Sex 0.0
Age 0.0
Diabetes 0.0
Hypertension 1.0
Smoking 2.4
Dyslipidemia 1.9
CKD 1.6
CVD 4.7
PVD 0
COPD 1.5
NYHA 0
CCS 0
Angina 1.2
MI 0.8
Angioplasty 0.0
Heavily calcified aorta 0.0
Coronary angiography data 0.0
LVEF 0.4
EUROSCORE II 0.0
STS 1.6
Urgent/emergent 0.0
REDO 0.0
Cardiopulmonary bypass time (minutes) 0.0
Aortic cross-clamping time (minutes) 0.0
Off-pump coronary artery bypass grafting 0.0
Number of distal anastomoses per patients 0.0
Coronary artery endarterectomy 0.0
Sequential anastomoses 0.0
LITA (DA-LAD) 0.0
Sequential anastomosis with the in-situ RITA 0.0
Left internal thoracic artery 0.0
Right internal thoracic artery 0.0
Grafted to the IA 0.0
Grafted to the OM 0.0
Grafted to the PL 0.0
Table S1 (continued)
Table S1 (continued)
Variables Percentage (%)
Retrocaval RITA routing 0.0
Radial artery employed 0.0
Grafted to RCA 0.0
Grafted to one of the marginal branches 0.0
Arterial grafts/patients 0.0
BITA arterial grafts/patients 0.0
Total arterial myocardial revascularization 0.0
Composite grafts 0.0
Surgical revision 0.0
Mortality 0.0
ICA unit stay 0.9
Mechanical ventilation hours 5.0
MCA 0.0
Surgical revision 0.0
Postoperative MI 0.0
Inotropes 0.4
Complications 0
CKD, chronic renal disease; CVD, cerebrovascular disease; 
PVD, peripheral vascular disease; COPD, chronic obstructive 
pulmonary disease; NYHA, New Heart Association Functional 
Class; CCS, Canadian Cardiovascular Society Angina Class; 
MI, myocardial infarction; LVEF, left ventricular ejection fraction; 
STS, Society of Thoracic Surgeons; LITA, left internal thoracic 
artery; DA, diagonal branch of left descending artery; LAD, 
left descending artery; RITA, right internal thoracic artery; IA, 
intermediate artery; OM, obtuse marginal artery; PL, postero-
lateral branch of the circumflex artery; RCA, right coronary 
artery; MCA, mechanical cardio-circulatory assistance.
